Zhejiang Starry Pharmaceutical Co (SHSE:603520) E10: ¥0.29 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603520 Zhejiang Starry Pharmaceutical Co Ltd SHSE:603520
76 GF Score
Price ¥8.38
GF Value ¥9.25
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Zhejiang Starry Pharmaceutical Co E10?

Zhejiang Starry Pharmaceutical Co SHSE:603520 +1.45% 76 E10 is ¥0.29 as of Jun. 2026. GuruFocus rates SHSE:603520 with a GF Score™ of 76/100 and a GF Value™ of ¥9.25 (Fairly Valued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Starry Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2026 was ¥0.043. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.29 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Zhejiang Starry Pharmaceutical Co's average E10 Growth Rate was -3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-09-17), Zhejiang Starry Pharmaceutical Co's current stock price is ¥8.38. Zhejiang Starry Pharmaceutical Co's E10 for the quarter that ended in Jun. 2026 was ¥0.29. Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio of today is 28.90.

During the past 13 years, the highest Shiller PE Ratio of Zhejiang Starry Pharmaceutical Co was 45.20. The lowest was 20.58. And the median was 30.17.


Zhejiang Starry Pharmaceutical Co  (SHSE:603520) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Starry Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=8.38/0.29
=28.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Zhejiang Starry Pharmaceutical Co was 45.20. The lowest was 20.58. And the median was 30.17.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zhejiang Starry Pharmaceutical Co E10 Related Terms


Zhejiang Starry Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Zhejiang Starry Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Starry Pharmaceutical Co E10 Chart

Zhejiang Starry Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.36 0.35 0.31 0.29

Zhejiang Starry Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.31 0.30 0.29 0.29

SHSE:603520 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Starry Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:603520
76GF Score
Zhejiang Starry Pharmaceutical Co Ltd SHSE:603520
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Starry Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Starry Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.0433/116.0564*116.0564
=0.043

Current CPI (Jun. 2026) = 116.0564.

Zhejiang Starry Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201609 0.047 102.400 0.054
201612 0.044 102.600 0.049
201703 0.084 103.200 0.094
201706 0.080 103.100 0.090
201709 0.047 104.100 0.053
201712 0.040 104.500 0.045
201803 0.066 105.300 0.072
201806 0.131 104.900 0.145
201809 0.060 106.600 0.066
201812 0.027 106.500 0.029
201903 0.124 107.700 0.134
201906 0.159 107.700 0.172
201909 0.135 109.800 0.143
201912 0.100 111.200 0.104
202003 0.139 112.300 0.144
202006 0.286 110.400 0.301
202009 0.179 111.700 0.186
202012 0.118 111.500 0.123
202103 0.189 112.662 0.194
202106 0.266 111.769 0.277
202109 0.187 112.215 0.193
202112 0.305 113.108 0.313
202203 0.235 114.335 0.238
202206 -0.047 114.558 -0.048
202209 -0.130 115.339 -0.131
202212 -0.279 115.116 -0.281
202303 0.028 115.116 0.028
202306 0.075 114.558 0.076
202309 0.012 115.339 0.012
202312 0.014 114.781 0.015
202403 0.036 115.227 0.036
202406 0.024 114.781 0.024
202409 -0.032 115.785 -0.032
202412 -0.133 114.893 -0.134
202503 0.033 115.116 0.033
202506 0.034 114.907 0.034
202509 -0.001 115.471 -0.001
202512 -0.042 115.832 -0.042
202603 0.048 116.303 0.048
202606 0.043 116.056 0.043

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.29 mean?
Zhejiang Starry Pharmaceutical Co (SHSE:603520) has a E10 of ¥0.29 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zhejiang Starry Pharmaceutical Co and its competitors.
Is Zhejiang Starry Pharmaceutical Co's E10 too high?
Zhejiang Starry Pharmaceutical Co's current E10 is ¥0.29. Overall, Zhejiang Starry Pharmaceutical Co has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Starry Pharmaceutical Co's E10 compare to ZTS?
Zhejiang Starry Pharmaceutical Co's E10 of ¥0.29 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zhejiang Starry Pharmaceutical Co and its competitors. Zhejiang Starry Pharmaceutical Co's current E10 is ¥0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Starry Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Starry Pharmaceutical Co (SHSE:603520) is currently considered Fairly Valued. The stock's GF Value™ is ¥9.25, compared to a current price of ¥8.38 — trading 9.4% below its estimated fair value. The current E10 is ¥0.29. Zhejiang Starry Pharmaceutical Co's overall GF Score™ is 76/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Zhejiang Starry Pharmaceutical Co (SHSE:603520), the current E10 is ¥0.29 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Starry Pharmaceutical Co (SHSE:603520) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Starry Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.38 is trading 9.4% below its estimated GF Value™ of ¥9.25. GuruFocus considers Zhejiang Starry Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603520:

  • E10: ¥0.29
  • GF Value™: ¥9.25 vs. price of ¥8.38 (9.4% below fair value)
  • GF Score™: 76/100 with 10 warning signs

No single metric tells the full story. See the SHSE:603520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Starry Pharmaceutical Co Business Description

Address No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
76GF Score

Get the complete analysis for SHSE:603520

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.38
Price
¥9.25
GF Value